1 000+ Malaria Industry reports covering 200 countries — revenue data, market shares and forecast 2026-2030.
Global malaria market to reach $1.2B by 2030 at 4.9% CAGR. Novartis, GSK, Cipla and Ipca lead the global competitive field. Prevalence, treatment & mortality forecasts by region, 2026-2030.
Asia malaria market to exceed $780M by 2030 at 5.1% CAGR. Key players include Cipla, Ipca Laboratories, Novartis and Ajanta Pharma. Incidence, mortality & treatment coverage data with 2026-2030 forecasts.
North America malaria market growing at 4.2% CAGR to 2030. GSK, Novartis and 60 Degrees Pharma lead regional supply. Treatment, prevention & prevalence forecasts, 2026-2030.
96%
of our customers give us a high rating on Trustpilot and G2 platforms